Cellular mechanisms of phagocytosis of Candida by murine macrophages

Advances in Cellular and Molecular Biology of Membranes and Organelles

Volumn 6, Issue C, 1999, Pages 317-331

  Káposzta, Rita ^a   Maródi, László ^a   Da Silva, Rosangela P ^b   Gordon, Siamon ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000779759     PISSN: 18745172     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5172(99)80018-2     Document Type: Review

References (27)

1. Arnold R.R., Brewer M., and Gauthier J.J. Bactericidal activity of human lactoferrin: Sensitivity of a variety of microorganisms. Infect. Immun. 28 (1980) 893-898
2. Balish E., Jensen J., Warner T., Brekke J., and Leonard B. Mucosal and disseminated candidiasis in gnotobiotic SCID mice. J. Med. Vet. Mycol. 31 (1993) 143-154
3. Beck-Sagué C.M., Jarvis W.R., and the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167 (1993) 1247-1251
4. Blasi E., Pitzurra L., and Puliti M. Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds. Infect. Immun. 63 (1995) 1806-1809
5. Calderone R.A. Recognition between Candida albicans and host cells. Trends in Microbiol. 2 (1993) 55-58
6. Casadevall A. Antibody immunity and invasive fungal infections. Infect. Immun. 63 (1995) 4211-4218
7. Cohen M.S., Isturiz R.E., and Malech H.L. Fungal infection in chronic granulomatous disease. Amer. J. Med. 71 (1981) 59-66
8. Fang F.C. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 99 (1997) 2818-2825
9. Ibrahim A.S., Mirbod F., Filler S.G., Banno Y., Cole G.T., Kitajima Y., Edwards Jr. J.E., Nazawa Y., and Ghannoum N.Y. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect. Immun. 63 (1995) 1993-1998
10. Káposzta R., Tree P., Maródi L., and Gordon S. Characteristics of invasive candidiasis in IFN-γ and IL-4 deficient mice; the role of macrophages in host defence against C. albicans. Infect. Immun. 66 (1998) 1708-1717
11. (In press). Káposzta R., da Silva R.P., Maródi L., Hollinshead M., and Gordon S. Rapid recruitment of late endosomes and lysosomes in mouse macrophages ingesting C. albicans. J. Cell Science (1999)
12. Lehrer R.I., and Cline M.J. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J. Clin. Invest. 2 (1969) 135-142
13. Lerner C.G., and Goldman C. Stimuli that induce production of Candida albicans extracellular aspartyl proteinase. J. Gen. Microbiol. 139 (1993) 1643-1651
14. Lo H.J., Köhler J.R., Didomenico B., Loebenberg D., Cacciapuoti A., and Fink G.R. Filamentous C. albicans mutants are avirulent. Cell 90 (1997) 939-949
15. Magee P.T. Which came first, the hypha or the yeast. Science 277 (1997) 52-53
16. Manns J.M., Mosser D.M., and Buckley H.R. Production of a hemolytic factor by Candida albicans. Infect. Immun. 62 (1994) 5152-5156
17. Maródi L., Korchak H.M., and Johnston Jr. R.B. Mechanism of host defense against Candida species I. Phagocytosis by monocytes and monocyte-derived macrophages. J. Immunol. 146 (1991) 2783-2789
18. Maródi L., Forehand J.R., and Johnston Jr. R.B. Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J. Immunol. 146 (1991) 2790-2794
19. Maródi L., Schreiber S., Anderson D.C., MacDermott R.P., Korchak H.M., and Johnston Jr. R.B. Enhancement of macrophage candidacidal activity by interferon-γ: Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Invest. 91 (1993) 2596-2601
20. Maródi L., Káposzta R., Campbell D.E., Polin R.A., Csongor J., and Johnston Jr. R.B. Candidacidal mechanisms in the human neonate: impaired IFN-gamma activation of macrophages in newborn infants. J. Immunol. 153 (1994) 5643-6549
21. Maródi L. Local and systemic defense mechanisms against Candida: immunopathology of candidal infections. Pediatr. Infect. Dis. J. 16 (1997) 795-801
22. Maródi L., Tournay C., Káposzta R., Johnston Jr. R.B., and Moguilevsky N. Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony stimulating factor. Infect. Immun. 66 (1998) 2750-2754
23. Marquis G., Montplasir S., Garzon S., Strykowski H., and Auger P. Fungitoxicity of muramidase: Ultrastructural damage to Candida albicans. Lab. Invest. 46 (1982) 627-632
24. Marquis G., Garzon S., Montplaisir S., Strykowski H., and Benhamou N. Histochemical and immunochemical study of the fate of Candida albicans inside human neutrophil phagolysosomes. J. Leuk. Biol. 50 (1991) 587-599
25. Shepherd M.G., Poulter R.T.M., and Sullivan P.A. Candida albicans: Biology, genetics, and pathogenicity. Ann. Rev. Microbiol. 39 (1985) 579-614
26. Vanquez-Torres A., Carson J., and Balish E. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect. Immun. 63 (1995) 1142-1144
27. Wang M., Friedman H., and Kjeu J.Y. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J. Immunol. 143 (1989) 571-677